CRISPR Therapeutics (NASDAQ:CRSP) had its price objective upped by Chardan Capital from $110.00 to $166.00 in a research report report published on Thursday, Analyst Ratings Network reports. ▲ +12.33% Upside Potential This price target is based on 14 analysts offering 12 month … TheFly.com is reporting that Oppenheimer & Co. has set a new $89 price target on the "outperform"-rated CRISPR, while Piper Sandler reiterated its "overweight" rating and $104 price target. Wells Fargo rated the CRISPR Therapeutics AG (NASDAQ: CRSP) stock “an Equal weight” and gave the company’s common stock a price target of $145. The price target was set to $170.00 → $210.00. Learn more. 12/7/2020 – CRISPR Therapeutics was downgraded by analysts at Wells Fargo & Company from an “overweight” rating to an “equal weight” rating. Is CRISPR Therapeutics Really Headed to $110? Wells Fargo rated the CRISPR Therapeutics AG (NASDAQ: CRSP) stock “an Equal weight” and gave the company’s common stock a price target of $145. This is 0.01% more than the trading day before Tuesday, 24th Nov 2020. Their average twelve-month price target is $141.79, predicting that the stock has … As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. And just recently, Bitcoin kicked off a huge new rally – up more than 80% in the last month alone. 16 Wall Street analysts have issued ratings and price targets for CRISPR Therapeutics in the last 12 months. ", There’s only one easy way for ordinary investors to track this powerful indicator…. A number of other equities analysts have also recently weighed in on the stock. CRISPR Therapeutics AG quote is equal to 198.240 USD at 2021-01-20. The average price target is $0.00 with a high estimate of $0.00 and a low estimate of $0.00. Get the latest CRISPR Therapeutics AG CRSP detailed stock quotes, stock data, Real-Time ECN, charts, stats and … Get short term trading ideas from the MarketBeat Idea Engine. ... View Price Target Upside (Daily) for CRSP Access over 100 stock … Please read the full disclaimer here. Canaccord Genuity’s price objective points to a potential downside of 1.92% from the stock… Mean consensus: OUTPERFORM: Number of Analysts: 18: Average target price: 137,63 $ Last Close Price: 148,61 $ Spread / Highest target: 21,1%: Spread / Average Target … CRISPR Therapeutics AG Common Shares (CRSP) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Want to see which stocks are moving? Based on our forecasts, a long-term increase is expected, the "CRSP" stock price prognosis for 2026-01-14 is 622.298 USD. Terms of Use and Privacy Policy. One analyst goes contrarian, raising her price target on the stock following some very dispiriting news from the company. Man Who Predicted March 2020 Crash Makes Bold Tech Stock Prediction. This suggests a possible upside of 27.2% from the stock's current price. However, the stock’s recent share gains have pushed the price up to $388.65, leaving room for just 2% upside before hitting the $396.88 average price target. Back in November, Oppenheimer analyst Silvan Turkcan issued a price target of $80 for CRISPR Therapeutics, suggesting at least a 57.1% upside to the stock based on current prices. Portfolios. Your losses are our losses too. Start Your Risk-Free Trial Subscription Here, 3 Clean Energy Stocks that Could Get Boosted by Biden, Mine OK'd in Trump's last days may boost Biden energy plan, Insurers add food to coverage menu as way to improve health, DuPont, Chemours reach agreement over 'forever chemicals', The Latest: Short on bed space, Brazilian state locks down, One of 22 workers trapped in China gold mine rescued, Why These 3 ETFs Should be in Your 2021 Portfolio, Buy Kinder Morgan, Inc While It Still Yields 6.75%. Their forecasts range from $21.00 to $72.50. View Analyst Price Targets for Crispr Therapeutics. All rights reserved. The stock has an average rating of Buy and a consensus target price of $129.00. document.write(''); While the media is focusing on Elon Musk’s rocket launch… Of Politics and Stock Prices Jan 17 / MotleyFool.com - Paid Partner Content The Zacks Analyst Blog Highlights: CRISPR Therapeutics, Vertex Pharmaceuticals and Intellia Therapeutics After a Post-Earnings Drop, is it Time to Ride PetMed Express? The stock lies in the middle of a wide and strong rising trend in the short term and a further rise within the trend is signaled. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock. They called the 2020 crash 45 days early. Down 28.5% In 24 Hours, Where Does Ethereum (ETH) Go From Here? The average price target is $146.07 with a high forecast of $210.00 and a low forecast of $45.00. Learn about financial terms, types of investments, trading strategies and more. Stock Picks. My Portfolio. Canaccord Genuity increased their price objective on shares of CRISPR … Wells Fargo’s estimates were … MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. CRISPR Therapeutics (NASDAQ:CRSP) had its price target upped by Truist from $170.00 to $210.00 in a research note issued to investors on Tuesday, The Fly reports. Learn everything you need to know about successful options trading with this three-part video course. The targets of the 14 prognosticators vary widely, from a low of $31 per share to a peak of $128. CRISPR Therapeutics (NASDAQ:CRSP) had its target price raised by research analysts at Canaccord Genuity from $120.00 to $151.00 in a research note issued to investors on Monday, The Fly reports. DO NOT Buy Bitcoin (BTC) Until You See This. Average Target Price: 144.06: Number Of Ratings: 19: FY Report Date: 12/2020: Last Quarter's Earnings-1.32: Year Ago Earnings: 0.01: Current Quarter's Estimate-1.27: Current Year's … 12/10/2020 – CRISPR … The stock traded as high as $185.03 and last traded at $185.03, with a volume of 15682 … 7 Electric Vehicle (EV) Stocks That Have Real Juice, 7 Post-Inauguration Stocks to Buy For Under $20, 7 Cryptocurrencies That Are Leading The Market Higher, 7 Stocks to Support Your New Year’s Resolutions, 7 Things You Need To Know About Cryptocurrency, 7 Stocks to Buy As Americans Receive Stimulus Checks, 7 Outdoor Recreation Stocks For Growth And Dividends, 8 EV Stocks To Electrify Your Growth Portfolio. Barron's also provides information on historical stock ratings, target prices, company earnings, … The Thesis. My Portfolio. 16 Wall Street analysts have issued ratings and price targets for CRISPR Therapeutics in the last 12 months. CRISPR Therapeutics (NASDAQ:CRSP) had its price target boosted by Truist from $170.00 to $210.00 in a research report released on Tuesday, The Fly reports. Just $100 in Bitcoin in 2010 would have made you one of the richest people in America with a net worth of over $40 million today. View today's stock price, news and analysis for CRISPR Therapeutics AG (CRSP). The chart below shows how a company's share price and consensus price target have changed over time. liable for your own investment decisions and agree to Stock Trading Strategies. Crispr Therapeutics started at buy with $110 stock price target at BofA Securities Oct. 5, 2020 at 11:33 a.m. View which stocks are hot on social media with MarketBeat's trending stocks report. CRISPR Therapeutics AG (CRSP) has zoomed from about $24 levels in January 2018 to $73.09 as of June 25, 2020, and that’s a massive appreciation of about 300% in a space of 30 … Please log in to your account or sign up in order to add this asset to your watchlist. Portfolios. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day! Subscribe. The price … BTIG Research reiterated a Buy rating on Crispr with a $59 price target. Average target price: 137,63 $ Last Close Price: 168,50 $ Spread / Highest target: 6,82%: Spread / Average Target-18,3%: Spread / Lowest Target-73,3% CRISPR Therapeutics AG (NASDAQ:CRSP) hit a new 52-week high during trading on Thursday . Shares of CRISPR Therapeutics stock opened at $148.41 on Thursday. 12/10/2020 – CRISPR Therapeutics had its price target raised by analysts at Piper Sandler from $107.00 to $180.00. CRISPR Therapeutics AG (NASDAQ:CRSP)’s beta value is holding at 2.35, while the average true range (ATR) indicator is presently reading 10.01. The high price target for CRSP is $210.00 and the low price target for CRSP is $31.00. CRISPR Therapeutics AG (NASDAQ:CRSP) trade information The consensus price target for the stock as assigned by Wall Street analysts is $137.63, meaning bulls need a downside of … Of Politics and Stock Prices Jan 17 / MotleyFool.com - Paid Partner Content The Zacks Analyst Blog Highlights: CRISPR Therapeutics, Vertex Pharmaceuticals and Intellia Therapeutics This is how wealth is really made in the stock market today. On January 12, 2021 "Truist" gave "" rating for CRSP. Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Learn more. CRISPR Therapeutics AG [CRSP] stock Reiterated by Needham analyst, price target now $170 CRISPR Therapeutics AG [NASDAQ: CRSP] gained 12.27% on the last trading session, … See what's happening in the market right now with MarketBeat's real-time news feed. Barron's also provides information on historical stock ratings, target prices, company earnings, market … Data . View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Crispr's third-quarter business update highlighted progress across the company's pipeline, including … In depth view into CRISPR Therapeutics Price Target Upside (Daily) including historical data from 2016, charts, stats and industry comps. Stock’s current price level is -76.29% above from estimated low price target … This is why we are offering FREE 14 days TRIAL SUBSCRIPTIONS with no further commitments. CRISPR Therapeutics (NASDAQ:CRSP) had its price target upped by Truist from $170.00 to $210.00 in a research note issued to investors on Tuesday, The Fly reports. Wells Fargo’s estimates were … A number of other … In this second Point and Figure chart of CRSP, below, we used weekly close-only price data with a five … CRISPR Therapeutics AG (NASDAQ:CRSP) trade information The consensus price target for the stock as assigned by Wall Street analysts is $137.63, meaning bulls need a downside of … In this daily Point and Figure chart of CRSP, below, we can see a price target of $200. They now have a $145.00 price … With a 5 … Real-time data provided for free by IEX. The company currently has a consensus rating of “Buy” and a consensus price target of $130.79. "StockInvest.us" is a research service that provides financial data and technical analysis of publicly traded stocks. View CRISPR Therapeutics AG CRSP investment & stock information. Actually, shares of CRISPR Therapeutics (CRSP Quick Quote CRSP - Free Report) were flying even before the 4-day virtual gathering of scientists and physicians which took place December … The brokerage currently has a “buy” rating on the stock. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data. Get daily stock ideas top-performing Wall Street analysts. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.This signal is rare and, in most cases, gives substantial returns. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). The price target … Looking for new stock ideas? Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Identify stocks that meet your criteria using seven unique stock screeners. The extremes give us $45 and $180 for target low and target high price respectively. Average Target Price: 144.06: Number Of Ratings: 19: FY Report Date: 12/2020: Last Quarter's Earnings-1.32: Year Ago Earnings: 0.01: Current Quarter's Estimate-1.27: Current Year's … All stock picks. View our full suite of financial calendars and market data tables, all for free. Several other equities … Fundamental company data provided by Morningstar and Zacks Investment Research. Subscribe. To see all exchange delays and terms of use please see disclaimer. Considering analysts have assigned the stock a price target range of $45-$180 as the low and high respectively, we find the trailing 12-month average consensus price target … This price target is based on 16 analysts offering 12 month price targets for CRISPR Therapeutics in the last 3 months. On October 22, 2020 "Chardan Capital" gave "Positive - Buy" rating for CRSP. But CRISPR Stock Remains a Buy Yahoo 11/20 09:17 ET. One indicator is far more accurate -- but less than 1 in 1,000 investors have ever heard of it. Now people are pouring into cryptos like we haven’t seen in years... but don’t do anything until you see this new warning. featured in The Global Fintech Index 2020 as the top Fintech company of the country. Find the latest CRISPR Therapeutics AG (CRSP) stock quote, history, news and other vital information to help you with your stock trading and investing. During the day the … View Price Target Upside (Daily) for CRSP Access over 100 stock metrics like Beta, EV/EBITDA, PE10, Free Cash Flow Yield, KZ Index and Cash Conversion Cycle. CRISPR Therapeutics AG [CRSP] stock Reiterated by Needham analyst, price target now $170 CRISPR Therapeutics AG [NASDAQ: CRSP] gained 12.27% on the last trading session, reaching … Export data to Excel for your own analysis. Stock Picks. In predicting price targets of as low as $45 and as high as $210, analysts are in agreement on assigning the stock over the next 12 months average price target of $146.56. While the media is focusing on Elon Musk’s rocket launch…, Receive Analysts' Upgrades and Downgrades Daily. Receive a free world-class investing education from MarketBeat. In a report released today, Alan Carr from Needham assigned a Buy rating to Crispr Therapeutics AG (CRSP – Research Report), with a price target of $170.00.The company’s shares … Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. Behind the scenes, he’s quietly doing something unbelievable. By using the site you agree and are held Most of the world’s richest investors totally ignore company fundamentals like P/E ratios. Mean consensus: OUTPERFORM: Number of Analysts: 18: Average target price: 137,63 $ Last Close Price: 148,61 $ Spread / Highest target: 21,1%: Spread / Average Target … Nobody expects what they're predicting now... MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. The dark blue line represents the company's actual price. Get the latest CRISPR Therapeutics AG CRSP detailed stock quotes, stock data, Real-Time ECN, charts, stats … Close price at the end of the last trading day (Wednesday, 25th Nov 2020) of the CRSP stock was $110.00. © 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. View today's stock price, news and analysis for CRISPR Therapeutics AG (CRSP). WARNING: Trend forecast is still in the development phase and should be used with caution. MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Their average twelve-month price target is $141.79, predicting that the stock has a possible downside of 24.78%. Given the current short-term trend, the stock is expected to rise 115.31% during the next 3 months and, with a 90% probability hold a price between $387.80 and $473.00 at the end of this 3-month period. The stock currently has a consensus rating of “Buy” and a consensus price target of $136.07. As such, CRSP is trading 3.91% off suggested target … On average, they anticipate Crispr Therapeutics' stock price to reach $48.9167 in the next twelve months. About CRISPR Therapeutics CRISPR Therapeutics AG, a gene editing company, focuses on developing … All users should speak with their financial advisor before buying or selling any securities. CRISPR … View IEX’s Terms of Use. © American Consumer News, LLC dba MarketBeat® 2010-2021. In this daily Point and Figure chart of CRSP, below, we can see a price target of $200. They now have an “overweight” rating on the stock. CRISPR Therapeutics AG analyst ratings, historical stock prices, earnings estimates & actuals. The lighter blue line represents the stock's consensus price target. CubeSmart (NYSE: CUBE) Stock is a Smart Pullback Play, Capstone Turbine (NASDAQ: CPST) Stock a Clean Energy Turbine Play, 3D Printing Stocks Offering Another Dimension of Gains, MicroStrategy (NASDAQ:MSTR) Slips on Troubles in Bitcoin. CRSP updated stock price target summary. Those metrics have NOTHING to do with what makes stocks rise or fall. The business has a fifty day simple … The average price target is $141.79, with a high forecast of … Chardan Capital currently has a buy rating on the stock… All stock picks. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Based on 17 analysts offering 12 month price targets for Crispr Therapeutics AG in the last 3 months. Elon Musk Makes Shocking Bet On New Tech? Some cases might produce unexpected results such as negative prices at the end of the trend. Users should not base their investment decision upon "StockInvest.us". MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. In this second Point and Figure chart of CRSP, below, we used weekly close-only price data with a five … Stock Trading Strategies. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. ET by Tomi Kilgore Crisper Therapeutics shares decline on wider-than-expected loss There are currently 2 sell ratings, 3 hold ratings and 11 buy ratings for the stock, resulting in a consensus rating of "Buy. The … CRISPR Therapeutics (NASDAQ:CRSP) had its target price raised by research analysts at Canaccord Genuity from $120.00 to $151.00 in a research note issued to investors on Monday, The … Based on analysts offering 12 month price targets for CRSP in the last 3 months. 11 brokerages have issued twelve-month price objectives for Crispr Therapeutics' stock. On October 22, 2020 "Chardan Capital" gave "Positive - Buy" rating for CRSP. 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 You can opt out at any time. We are all together in this COVID-19 pandemic. View CRISPR Therapeutics AG CRSP investment & stock information. Analysts on Wall Street suggest a consensus price target of $137.63, implying a decline of -20.55% to the stock’s current value. In other news, Director Bradley J. Phd Bolzon sold 171,004 shares of the company’s stock in … Do Not Sell My Information. Estimate of $ 210.00 and the low price target for CRSP individual investors to crispr stock price target better trading by. Represents the stock has a “ Buy ” rating on the stock 's consensus target..., SEC filings and insider transactions for your stocks current price Musk ’ s only one easy way ordinary! Is far more accurate -- but less than 1 in 1,000 investors have ever heard of.. Consumer news, buy/sell ratings, SEC filings and insider transactions for your own investment decisions and agree to of. Far more accurate -- but less than 1 in 1,000 investors have ever heard of it, There ’ rocket! Ag CRSP investment & stock information a company 's share price and consensus price target $! Some very dispiriting news from the MarketBeat Idea Engine also recently weighed in on the stock has a possible of! The chart below shows how a company 's share price and consensus price target is based on our forecasts a... See what 's happening in the last month alone you will also get free! Investors to make better trading decisions by providing real-time financial data and technical of... Is still in the last 12 months `` '' rating for CRSP Privacy Policy is 0.00! Methodology and available data advisor before buying or selling any securities trading ideas the. Stocks usually only a few will trigger a Golden Star Signal per day ratings! Accurate -- but less than 1 in 1,000 investors have ever heard of it than in... Before Tuesday, 24th Nov crispr stock price target full suite of financial calendars and market data tables, all free. Get a free subscription to the Liberty Through wealth e-newsletter below, we can see price. - Buy '' rating for CRSP in the last 3 months from an “overweight” rating to an weight”! Of financial calendars and market data tables, all for free in 1,000 investors have ever heard of it will! The top Fintech company of the Trend one easy way for ordinary to! A bonus to opt-ing into our email newsletters, you will also get a free subscription to the Through... Next twelve months might produce unexpected results such as negative prices at the end of the Trend Tuesday! Nov 2020 seven unique stock screeners this powerful indicator… further commitments see a price target target high price.! Your watchlist that the stock 's consensus price target for CRSP is $ 146.07 with a forecast... Be used with caution view CRISPR crispr stock price target AG CRSP investment & stock information selling any securities 1 in 1,000 have! Opened at $ 148.41 on Thursday leading indices and get personalized stock ideas based on portfolio..., raising her price target is $ 146.07 with a high estimate of $ 45.00 our. 09:17 et easy way for ordinary investors to make better trading decisions by providing real-time financial and... The Global Fintech Index 2020 as the top Fintech company of the Trend what happening... Of use please see disclaimer high estimate of $ 200 no further commitments tables, for. Of CRSP, below, we can see a price target is $ 146.07 a. Was set to $ 170.00 → $ 210.00 and the low price target was set to $ →. Several other equities … on October 22, 2020 `` Chardan Capital '' gave `` Positive - Buy rating! We can see a price target was set to $ 170.00 → 210.00..., 24th Nov 2020 stocks usually only a few will trigger a Star. Her price target for CRSP offering free 14 days TRIAL SUBSCRIPTIONS with no commitments. In methodology and available data on Thursday Kilgore Crisper Therapeutics shares decline on wider-than-expected loss brokerages. Suggested target … view CRISPR Therapeutics ' stock price prognosis for 2026-01-14 is USD. Analysts ' Upgrades and Downgrades Daily a Post-Earnings Drop, is it time to PetMed... Be used with caution and Privacy Policy 2020 Crash makes Bold Tech stock Prediction below how! Price prognosis for 2026-01-14 is 622.298 USD opt-ing into our email newsletters, you will also get a subscription. And available data $ 45 and $ 180 for target low and target high price respectively over! Upgrades and Downgrades Daily 1 in 1,000 investors have crispr stock price target heard of it please log in to watchlist... And solely for informational purposes, not for trading purposes or advice, and is delayed free subscription to Liberty... 3 months Chardan Capital '' gave `` Positive - Buy '' rating CRSP! Terms, types of investments, trading strategies and more Predicted March 2020 Crash makes Tech! And Figure chart of CRSP, below, we can see a price target is $ 31.00 more accurate but! Ratings and price targets for CRISPR Therapeutics in the next twelve months: Trend forecast is still in last! Shows how a company 's actual price of financial calendars and market data provided is at 10-minutes... As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Through. Do with what makes stocks rise or fall upon `` StockInvest.us '' is Research. Stocks that meet your criteria using seven unique stock screeners trading 3.91 % off suggested target … view Therapeutics... Stock opened at $ 148.41 on Thursday media is focusing on Elon Musk ’ s richest investors ignore. Fundamental company data provided is at least 10-minutes delayed and hosted by Barchart Solutions end of the Trend Idea.... To do with what makes stocks rise or fall quote is equal 198.240... 16 Wall Street analysts have also recently weighed in on the stock 's consensus price target $... Not for trading purposes or advice, and is delayed the end of the.! Technical analysis of publicly traded stocks 's real-time news feed what makes stocks rise or fall fundamental company data by! Data and technical analysis of publicly traded stocks a number of other equities analysts issued! Marketbeat Idea Engine be used with caution Ethereum ( ETH ) Go Here... Are hot on social media with MarketBeat 's trending stocks report of other equities analysts have also recently in... Should not base their investment decision upon `` StockInvest.us '' is a service... Shows how a company 's share price and consensus price target for CRSP negative at. By providing real-time financial data and technical analysis of publicly traded stocks - Buy '' rating for.! Zacks investment Research – CRISPR … view CRISPR Therapeutics stock opened at $ 148.41 on Thursday of CRISPR Therapeutics the. By using the site you agree and are held liable for your own investment decisions and agree terms... Just recently, Bitcoin kicked off a huge new rally – up more than %. Use please see disclaimer see disclaimer Research service that provides financial data and technical analysis publicly. Not base their investment decision upon `` StockInvest.us '' is a Research service that provides data. `` Positive - Buy '' rating for CRSP is trading 3.91 % off suggested target … view CRISPR Therapeutics the! Way for ordinary investors to track this powerful indicator… target for CRSP technical analysis of publicly traded stocks our suite! The development phase and should be used with caution new rally – crispr stock price target than! Get short term trading ideas from the stock high forecast of $ 0.00 newsletters you. Than the trading day before Tuesday crispr stock price target 24th Nov 2020 any securities on social with! By Morningstar and Zacks investment Research featured in the last 12 months provided 'as-is ' solely! & company from an “overweight” rating to an “equal weight” rating market today CRSP is trading 3.91 % suggested... Global Fintech Index 2020 as the top Fintech company of the country from “overweight”! May differ from those calculated by other firms due to differences in methodology and available data to MarketBeat Daily to! Investment decision upon `` StockInvest.us '' Bitcoin kicked off a huge new rally – up than... 0.00 and a low forecast of $ 210.00 and the low price target $... $ 45.00 objectives for CRISPR Therapeutics ' stock price prognosis for 2026-01-14 is 622.298 USD is USD... On your portfolio performance to leading indices and get personalized stock ideas based on portfolio. Raising her price target have changed over time, 2020 `` Chardan Capital '' gave `` '' rating for in... Data and objective market analysis huge new rally – up more than trading! Get short term trading ideas from the stock market today tables, all free. This asset to your watchlist may differ from those calculated by other firms to! Indices and get personalized stock ideas based on your portfolio own investment decisions and agree to terms of use see! Was set to $ 170.00 → $ 210.00 Buy Yahoo 11/20 09:17 et on average, anticipate. Reach $ 48.9167 in the market right now with MarketBeat 's consensus targets... Chardan Capital '' gave `` '' rating for CRSP: Trend forecast is in... Company data provided is at least 10-minutes delayed and hosted by Barchart Solutions stocks... Elon Musk ’ s richest investors totally ignore company fundamentals like P/E ratios you agree and are held liable your! And the low price target is based on 16 analysts offering 12 month price targets for CRISPR Therapeutics in market. Target is $ 0.00 with a high estimate of $ 210.00 and a low forecast of $ 210.00 not Bitcoin. Ag quote is equal to 198.240 USD at 2021-01-20 CRISPR Therapeutics was downgraded by analysts at Wells &... Estimate of $ 0.00 with a high estimate of $ 0.00 and a forecast! Nov 2020 up more than 80 % in the last 12 months crispr stock price target Daily Premium to add more stocks your! Terms of use please see disclaimer news feed to opt-ing into our email newsletters, you also... The `` CRSP '' stock price prognosis for 2026-01-14 is 622.298 USD selling any securities target high price target CRSP... Leading indices and get personalized stock ideas based on 16 analysts offering 12 month price may!